High Intensity Focused Ultrasound Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer
Conditions: Pancreatic Cancer Non-resectable; Chemotherapy Effect; Ultrasound Therapy Interventions: Device: ALPIUS 900, an ultrasound-guided high intensity focused ultrasound system; Drug: FOLFIRINOX regimen Sponsors: Seoul National University Hospital; Focused Ultrasound Foundation; Synex Consulting Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials
